Patients with diabetes and coronary artery disease who underwent coronary artery bypass grafting showed a lower mortality risk compared with those who had percutaneous coronary intervention with a drug-eluting stent, a study indicated. However, the CABG patients had a higher risk of nonfatal myocardial infarction than those in the PCI group, researchers wrote in the Journal of the American College of Cardiology.
Study compares CABG, PCI for patients with diabetes, CAD
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|